logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Complicated Skin And Skin Structure Infection

    Medications for Complicated Skin And Skin Structure Infection

    FiltersReset Filters
    25 results
    • ampicillin and sulbactam

      (Ampicillin sodium and Sulbactam sodium)
      Hospira, Inc
      Usage: Ampicillin and sulbactam for injection is indicated for treating infections caused by susceptible strains in skin, intra-abdominal, and gynecological infections. It targets beta-lactamase producing organisms and can also be used for mixed infections involving ampicillin-susceptible bacteria, following appropriate culture and susceptibility testing.
    • ampicillin and sulbactam

      (Ampicillin Sodium and Sulbactam Sodium)
      Eugia US LLC
      Usage: Ampicillin and sulbactam for injection is indicated for treating infections from susceptible microorganisms in skin and skin structure infections, intra-abdominal infections, and gynecological infections. It is effective against beta-lactamase producing strains of various bacteria, while also addressing mixed infections involving ampicillin-susceptible organisms.
    • ampicillin sodium and sulbactam sodium

      (ampicillin sodium, sulbactam sodium)
      Armas Pharmaceuticals Inc.
      Usage: Ampicillin and sulbactam for injection is indicated for treating skin and skin structure infections, intra-abdominal infections, and gynecological infections caused by beta-lactamase producing organisms, including specific strains of Escherichia coli, Klebsiella, Bacteroides, and others. It is also effective against ampicillin-susceptible organisms.
    • azactam

      (AZTREONAM)
      E.R. Squibb & Sons, L.L.C.
      Usage: AZACTAM is indicated for treating infections caused by susceptible Gram-negative bacteria, including urinary tract, lower respiratory tract, septicemia, skin and skin-structure, intra-abdominal, and gynecologic infections. It is also used adjunctively in surgical management of infections. Concurrent therapy with other antimicrobials may be necessary in seriously ill patients.
    • ceftriaxone sodium

      (Ceftriaxone Sodium)
      Hospira, Inc
      Usage: Ceftriaxone is indicated for treating infections caused by susceptible bacteria, including lower respiratory tract infections, acute bacterial otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, septicemia, bone and joint infections, intra-abdominal infections, meningitis, and for surgical prophylaxis.
    • ceftriaxone sodium

      (Ceftriaxone Sodium)
      Hospira, Inc
      Usage: Ceftriaxone is indicated for treating infections caused by susceptible bacteria, including lower respiratory infections, acute bacterial otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, septicemia, bone and joint infections, intra-abdominal infections, meningitis, and for surgical prophylaxis against postoperative infections.
    • ceftriaxone sodium

      (Ceftriaxone Sodium)
      Hospira, Inc
      Usage: Ceftriaxone is indicated for treating various infections caused by susceptible bacteria, including lower respiratory tract infections, acute bacterial otitis media, skin and skin structure infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, intra-abdominal infections, meningitis, and for surgical prophylaxis.
    • ciprofloxacin in dextrose

      (ciprofloxacin)
      Hospira, Inc.
      Usage: Ciprofloxacin Injection is indicated for treating various infections in adults, including skin, bone and joint, complicated intra-abdominal, nosocomial pneumonia, febrile neutropenia, inhalational anthrax (post-exposure), plague, chronic bacterial prostatitis, lower respiratory tract infections, complicated urinary tract infections, and acute sinusitis.
    • daptomycin

      (daptomycin)
      Mylan Institutional LLC
      Usage: Daptomycin for injection is indicated for treating complicated skin and skin structure infections in adults and pediatric patients (1-17 years) caused by susceptible Gram-positive bacteria, and for Staphylococcus aureus bloodstream infections (bacteremia) in both adult and pediatric patients. Not recommended for pneumonia or left-sided infective endocarditis.
    • daptomycin

      (daptomycin)
      Mylan Institutional LLC
      Usage: Daptomycin for injection is indicated for treating complicated skin and skin structure infections (cSSSI) and Staphylococcus aureus bloodstream infections (bacteremia) in adults and pediatric patients (1-17 years). It is not recommended for pneumonia or left-sided infective endocarditis and should not be used in patients younger than 1 year.